PlainRecalls
FDA Drug Low Class III Terminated

Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.

Reported: October 7, 2015 Initiated: July 21, 2015 #D1834-2015

Product Description

Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.

Reason for Recall

Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.

Details

Recalling Firm
Apotex Inc.
Units Affected
2,075 bottles
Distribution
Nationwide and Puerto Rico
Location
Toronto, Ontario

Frequently Asked Questions

What product was recalled?
Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.. Recalled by Apotex Inc.. Units affected: 2,075 bottles.
Why was this product recalled?
Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 7, 2015. Severity: Low. Recall number: D1834-2015.